検索に戻る
案件記録
CHROMAN DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
発明審査中
76請求項 · 3 独立
§ Ⅰ
案件概要
出願人
THE REGENTS OF THE UNIVERSITY OF MICHIGAN; Oncopia Therapeutics, Inc. d/b/a SK Life Science Labs
発明者
Guozhang Xu; Ranjan Kumar Acharyya; Rohan Rej; Zhixiang Chen; Biao Hu; Jianfeng Lu; Shaomeng Wang
IPC分類
A61K 31/5383A61K 31/438A61K 31/444A61P 35/C7D 405/14C7D 491/147C7D 498/14C7D 519/
CPC分類
A61K31/5383A61K31/438A61K31/444A61P35/C7D405/14C7D491/147C7D498/14C7D519/
Described herein are compounds of Formula (I) and pharmaceutically acceptable salts, solvates, or stereoisomers thereof, as well as their uses (e.g., as estrogen receptor degraders).
原文（中国語）
Described herein are compounds of Formula (I) and pharmaceutically acceptable salts, solvates, or stereoisomers thereof, as well as their uses (e.g., as estrogen receptor degraders).
外部リソース